Viewing Study NCT00457067


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-01-04 @ 6:04 PM
Study NCT ID: NCT00457067
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2007-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation
Sponsor: National Eye Institute (NEI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Telangiectasia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hyperfluorescence on Fluorescein View
None Idiopathic Juxtafoveal Telangiectasia View
None Retinal Edema/Thinning View
None Vascular Endothelial Growth Factor View
None Macular Telangiectasia View